ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,572.85
      0.10%
      US Tech 100
      19,968.80
      0.38%
      Dow Jones
      39,344.79
      -0.08%
      Brent Oil
      85.20
      -0.25%
      Bitcoin
      57,465.55
      1.34%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Vertex Pharmaceuticals Inc (VRTX)

      7. Vertex Pharmaceuticals Inc (VRTX) News

      VRTX

      Vertex Pharmaceuticals (VRTX)

      Vertex Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:VRTX
      DateTimeSourceHeadlineSymbolCompany
      08/02/20224:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
      07/27/20222:15AMTipRanksSVB Securities Sticks to Its Hold Rating for Vertex Pharmaceuticals (VRTX)NASDAQ:VRTXVertex Pharmaceuticals Inc
      07/22/20228:00AMBusiness WireVertex Advances VX-548 in Acute and Neuropathic PainNASDAQ:VRTXVertex Pharmaceuticals Inc
      07/21/20224:49PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
      07/20/20225:52PMDow Jones NewsVerve Therapeutics Shares Fall 14%, Company Commences Public OfferingNASDAQ:VRTXVertex Pharmaceuticals Inc
      07/20/20224:01PMGlobeNewswire Inc.Vertex and Verve Therapeutics Establish Collaboration to Discover and Develop an In Vivo Gene Editing Program for Liver DiseaseNASDAQ:VRTXVertex Pharmaceuticals Inc
      07/19/20224:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
      07/18/20224:05PMBusiness WireVertex to Announce Second Quarter 2022 Financial Results on August 4NASDAQ:VRTXVertex Pharmaceuticals Inc
      07/14/20222:15AMTipRanksWall Street Analysts Are Neutral on Top Healthcare PicksNASDAQ:VRTXVertex Pharmaceuticals Inc
      07/11/20228:14AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VRTXVertex Pharmaceuticals Inc
      07/11/20228:00AMBusiness WireVertex to Acquire ViaCyte, With the Goal of Accelerating its Potentially Curative VX-880 Programs in Type 1 DiabetesNASDAQ:VRTXVertex Pharmaceuticals Inc
      07/08/202210:06PMTipRanksVertex Pharmaceuticals (VRTX) Gets a Hold Rating from RBC CapitalNASDAQ:VRTXVertex Pharmaceuticals Inc
      07/07/202210:45PMTipRanksAnalysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), AbbVie (ABBV) and Sarepta Therapeutics (SRPT)NASDAQ:VRTXVertex Pharmaceuticals Inc
      07/07/20222:36PMPR Newswire (Canada)Vertex procède à l'annonce de la lettre d'intention avec l'Alliance pancanadienne pharmaceutique pour le remboursement public de TRIKAFTA(MD) (éléxacaftor/tézacaftor/ivacaftor et ivacaftor) chez les enfants âgés de 6 ans et plus atteints de fibroseNASDAQ:VRTXVertex Pharmaceuticals Inc
      07/07/20222:26PMPR Newswire (Canada)Vertex Announces Letter of Intent With the pan-Canadian Pharmaceutical Alliance for Public Reimbursement of TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Children With Cystic Fibrosis Ages 6 and OlderNASDAQ:VRTXVertex Pharmaceuticals Inc
      07/05/20225:09PMBusiness WireVertex annonce que la FDA a levé la suspension clinique de l'essai clinique de phase 1/2 du VX-880 pour le traitement du diabète de type 1NASDAQ:VRTXVertex Pharmaceuticals Inc
      07/05/20225:09PMBusiness WireVertex: FDA hebt Stopp der klinischen Phase 1/2-Studie zu VX-880 für die Behandlung von Typ 1 Diabetes aufNASDAQ:VRTXVertex Pharmaceuticals Inc
      07/05/20228:45AMDow Jones NewsVertex: FDA Lifts Clinical Hold on VX-880 Study in Type 1 DiabetesNASDAQ:VRTXVertex Pharmaceuticals Inc
      07/05/20228:00AMBusiness WireVertex Announces FDA Has Lifted the Clinical Hold on VX-880 Phase 1/2 Clinical Trial for the Treatment of Type 1 DiabetesNASDAQ:VRTXVertex Pharmaceuticals Inc
      07/03/202210:48PMTipRanksVertex Pharmaceuticals (VRTX) Receives a Hold from SVB SecuritiesNASDAQ:VRTXVertex Pharmaceuticals Inc
      06/28/20224:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
      06/14/20227:35AMTipRanksMaxim Group Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX)NASDAQ:VRTXVertex Pharmaceuticals Inc
      06/13/20229:45PMTipRanksVertex Pharmaceuticals (VRTX) Gets a Hold Rating from RBC CapitalNASDAQ:VRTXVertex Pharmaceuticals Inc
      06/11/20223:00AMBusiness WireVertex and CRISPR Therapeutics Present New Data on More Patients With Longer Follow-Up Treated With exagamglogene autotemcel (exa-cel) at the 2022 European Hematology Association (EHA) CongressNASDAQ:VRTXVertex Pharmaceuticals Inc
      06/10/202211:00AMBusiness WireVertex to Present Data Demonstrating Significant Benefits of Long-Term and Early Treatment With CFTR Modulators at the European Cystic Fibrosis ConferenceNASDAQ:VRTXVertex Pharmaceuticals Inc
      06/08/20224:05PMBusiness Wire Vertex to Participate in the Goldman Sachs 43rd Annual Healthcare Conference on June 15NASDAQ:VRTXVertex Pharmaceuticals Inc
      06/08/202212:35PMTipRanksAnalysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Aldeyra Therapeutics (ALDX)NASDAQ:VRTXVertex Pharmaceuticals Inc
      06/08/20228:00AMBusiness WireVertex Announces Inaxaplin (VX-147) Granted Breakthrough Therapy Designation by U.S. FDA and Priority Medicines (PRIME) Designation by the EMANASDAQ:VRTXVertex Pharmaceuticals Inc
      06/07/20227:14AMBusiness WireVertex präsentiert neue Daten aus der klinischen Phase-1/2-Studie zu VX-880 bei den 82. Scientific Sessions der American Diabetes AssociationNASDAQ:VRTXVertex Pharmaceuticals Inc
      06/07/20227:14AMBusiness WireVertex présente de nouvelles données sur l'essai clinique de Phase 1 du VX-880 dans le cadre des 82e sessions scientifiques de l'American Diabetes AssociationNASDAQ:VRTXVertex Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:VRTX